Adaptive unveils data of MRD assessment test in blood cancer treatment
Adaptive Biotechnologies has unveiled new data highlighting the significant role of measurable residual disease (MRD) assessment in the treatment of…
Hematological Disorders
-
-
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
The US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay as a companion diagnostic to Pfizer’s…
-
Penumbra secures FDA clearance for Lightning Flash 2.0 thrombectomy system
US-based thrombectomy company Penumbra has secured FDA clearance and launched its Lightning Flash 2.0, a next-generation computer-assisted vacuum thrombectomy (CAVT)…
-
BD to advance bloodstream infections testing in Poland
Becton, Dickinson and Company (BD) has partnered with Poland's non-governmental non-profit organisation The Great Orchestra of Christmas Charity (GOCC) to…
-
BillionToOne collabs with J&J for Phase III pregnancy trial
J&J has signed a collaboration agreement with BillionToOne (BTO) to supply screening assays for the Phase III AZALEA trial investigating…
